Budigalimab, CAS 2098225-93-3

Product Description: Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Powderly J, et al. Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181). Clin Transl Sci. 2021 Jan;14(1):277-287.

CAS Number: 2098225-93-3

Molecular Weight: N/A

Compound Purity: 99.79

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99489-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99489-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated